WallStreetZenWallStreetZen

NASDAQ: LEGN
Legend Biotech Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for LEGN

Based on 8 analysts offering 12 month price targets for Legend Biotech Corp

Min Forecast
$29.00+3.61%
Avg Forecast
$58.50+109%
Max Forecast
$80.00+185.82%

Should I buy or sell LEGN stock?

Based on 8 analysts offering ratings for Legend Biotech Corp.

Strong Buy
Strong Buy
4 analysts 50%
Buy
3 analysts 37.5%
Hold
1 analysts 12.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although LEGN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates LEGN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their LEGN stock forecasts and price targets.

LEGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-18
lockedlocked$00.00+00.00%2026-05-13
lockedlocked$00.00+00.00%2026-05-13
lockedlocked$00.00+00.00%2026-05-13
lockedlocked$00.00+00.00%2026-02-04
Oppenheimer
Top 20%
81
BuyInitiates Coverage On$75.00+167.95%2026-01-07
Cantor Fitzgerald
Top 34%
67
Strong BuyMaintains$74.00+164.38%2025-12-17
UBS
Top 11%
90
Strong BuyMaintains$48.00+71.49%2025-12-08

1 of 1

Forecast return on equity

Is LEGN forecast to generate an efficient return?

Company
76.33%
Industry
85.8%
Market
169.74%
LEGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LEGN forecast to generate an efficient return on assets?

Company
46.26%
Industry
29.42%
LEGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LEGN earnings per share forecast

What is LEGN's earnings per share in the next 3 years based on estimates from 21 analysts?

Avg 1 year Forecast
$0.23
Avg 2 year Forecast
$1.03
Avg 3 year Forecast
$1.63

LEGN revenue forecast

What is LEGN's revenue in the next 3 years based on estimates from 21 analysts?

Avg 1 year Forecast
$1.5B+28.38%
Avg 2 year Forecast
$1.9B+67.02%
Avg 3 year Forecast
$2.3B+100.13%
LEGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LEGN revenue growth forecast

How is LEGN forecast to perform vs Biotechnology companies and vs the US market?

Company
26.24%
Industry
36.05%
Market
13.75%
LEGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LEGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LEGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LEGN$27.99$58.50+109.00%Strong Buy
XENE$54.12$76.89+42.07%Strong Buy
DNTH$89.63$126.27+40.88%Strong Buy
LQDA$61.97$55.33-10.71%Buy
COGT$32.58$56.80+74.34%Strong Buy
View Top Biotech Stocks

Legend Biotech Stock Forecast FAQ

Is Legend Biotech Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: LEGN) stock is to Strong Buy LEGN stock.

Out of 8 analysts, 4 (50%) are recommending LEGN as a Strong Buy, 3 (37.5%) are recommending LEGN as a Buy, 1 (12.5%) are recommending LEGN as a Hold, 0 (0%) are recommending LEGN as a Sell, and 0 (0%) are recommending LEGN as a Strong Sell.

If you're new to stock investing, here's how to buy Legend Biotech stock.

What is LEGN's earnings growth forecast for 2026-2028?

(NASDAQ: LEGN) Legend Biotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.87%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.38%.

Legend Biotech's earnings in 2026 is -$250,269,000.On average, 21 Wall Street analysts forecast LEGN's earnings for 2026 to be $85,291,712, with the lowest LEGN earnings forecast at -$72,809,998, and the highest LEGN earnings forecast at $261,335,887. On average, 20 Wall Street analysts forecast LEGN's earnings for 2027 to be $383,106,894, with the lowest LEGN earnings forecast at $42,237,229, and the highest LEGN earnings forecast at $747,342,625.

In 2028, LEGN is forecast to generate $606,106,088 in earnings, with the lowest earnings forecast at $61,888,499 and the highest earnings forecast at $1,330,082,647.

What is LEGN's revenue growth forecast for 2026-2028?

(NASDAQ: LEGN) Legend Biotech's forecast annual revenue growth rate of 26.24% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 36.05%, and while it is forecast to beat the US market's average forecast revenue growth rate of 13.75%.

Legend Biotech's revenue in 2026 is $1,138,788,000.On average, 21 Wall Street analysts forecast LEGN's revenue for 2026 to be $543,103,150,346, with the lowest LEGN revenue forecast at $475,865,345,823, and the highest LEGN revenue forecast at $605,511,720,290. On average, 20 Wall Street analysts forecast LEGN's revenue for 2027 to be $706,554,166,866, with the lowest LEGN revenue forecast at $584,708,863,642, and the highest LEGN revenue forecast at $811,311,409,272.

In 2028, LEGN is forecast to generate $846,601,969,657 in revenue, with the lowest revenue forecast at $661,605,137,323 and the highest revenue forecast at $1,074,318,954,036.

What is LEGN's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: LEGN) forecast ROA is 46.26%, which is higher than the forecast US Biotechnology industry average of 29.42%.

What is LEGN's Price Target?

According to 8 Wall Street analysts that have issued a 1 year LEGN price target, the average LEGN price target is $58.50, with the highest LEGN stock price forecast at $80.00 and the lowest LEGN stock price forecast at $29.00.

On average, Wall Street analysts predict that Legend Biotech's share price could reach $58.50 by May 18, 2027. The average Legend Biotech stock price prediction forecasts a potential upside of 109% from the current LEGN share price of $27.99.

What is LEGN's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: LEGN) Legend Biotech's current Earnings Per Share (EPS) is -$1.36. On average, analysts forecast that LEGN's EPS will be $0.23 for 2026, with the lowest EPS forecast at -$0.20, and the highest EPS forecast at $0.70. On average, analysts forecast that LEGN's EPS will be $1.03 for 2027, with the lowest EPS forecast at $0.11, and the highest EPS forecast at $2.01. In 2028, LEGN's EPS is forecast to hit $1.63 (min: $0.17, max: $3.58).

What is LEGN's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: LEGN) forecast ROE is 76.33%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.